Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$547.01 - $662.35 $132 Million - $160 Million
-241,517 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $79.9 Million - $101 Million
-156,456 Reduced 39.31%
241,517 $141 Million
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $24.4 Million - $28.7 Million
-53,606 Reduced 11.87%
397,973 $205 Million
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $1.26 Million - $1.86 Million
-3,769 Reduced 0.83%
451,579 $204 Million
Q1 2020

May 12, 2020

SELL
$320.01 - $409.07 $94.2 Million - $120 Million
-294,481 Reduced 39.27%
455,348 $160 Million
Q4 2019

Feb 12, 2020

SELL
$319.73 - $374.2 $1.11 Million - $1.3 Million
-3,463 Reduced 0.46%
749,829 $277 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $713,560 - $808,897
-2,343 Reduced 0.31%
753,292 $251 Million
Q2 2019

Aug 13, 2019

BUY
$286.93 - $312.59 $1.58 Million - $1.73 Million
5,522 Added 0.74%
755,635 $236 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $245,159 - $346,929
1,093 Added 0.15%
750,113 $229 Million
Q4 2018

Feb 12, 2019

SELL
$220.1 - $309.0 $125 Million - $176 Million
-569,115 Reduced 43.18%
749,020 $174 Million
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $41.8 Million - $47.1 Million
-144,418 Reduced 9.87%
1,318,135 $413 Million
Q2 2018

Aug 14, 2018

SELL
$244.1 - $303.88 $1.76 Million - $2.19 Million
-7,194 Reduced 0.49%
1,462,553 $422 Million
Q1 2018

May 14, 2018

SELL
$233.97 - $274.11 $1.2 Million - $1.41 Million
-5,128 Reduced 0.35%
1,469,747 $368 Million
Q4 2017

Feb 12, 2018

SELL
$216.94 - $271.3 $21.9 Million - $27.4 Million
-100,847 Reduced 6.4%
1,474,875 $352 Million
Q3 2017

Nov 14, 2017

SELL
$212.27 - $242.28 $15.2 Million - $17.3 Million
-71,478 Reduced 4.34%
1,575,722 $350 Million
Q2 2017

Aug 15, 2017

BUY
N/A
1,647,200
1,647,200 $373 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Atlanta Capital Management CO L L C Portfolio

Follow Atlanta Capital Management CO L L C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Capital Management CO L L C, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Capital Management CO L L C with notifications on news.